What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?
ALTPfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid obesity drug competition.
8 Analysts Assess Altimmune: What You Need To Know
ALTHC Wainwright & Co. Reiterates Buy on Altimmune, Maintains $12 Price Target
ALTCitizens Capital Markets Reiterates Market Outperform on Altimmune, Maintains $25 Price Target
ALTHC Wainwright & Co. Reiterates Buy on Altimmune, Maintains $12 Price Target
ALTWatching Altimmune; Traders Circulate M&A Blog Comments Suggesting Multiple Large Pharma Co's Interested In The Company
ALTCitizens Capital Markets Reiterates Market Outperform on Altimmune, Maintains $25 Price Target
ALTAltimmune Expands Weight-Loss Drug Pemvidutide's Potential To Alcohol-Related Disorders
ALTAltimmune plans Phase 2 trials in 2025 for pemvidutide in alcohol use disorder and liver disease, highlighting weight loss and liver health benefits.
Altimmune Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
ALTHC Wainwright & Co. Reiterates Buy on Altimmune, Maintains $12 Price Target
ALTThis CoStar Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
ALTWilliam Blair Initiates Coverage On Altimmune with Market Perform Rating
ALTAltimmune Q4 2024 GAAP EPS $(0.33), Inline, Sales $5.00K Down From $37.00K YoY, Cash, Cash Equivalents And Short-term Investments Of $131.9M
ALTAltimmune Will Be Added To The Nasdaq Biotechnology Index Effective Prior To The Market Open On December 23, 2024
ALTAltimmune Presents New Data On The Effect Of Pemvidutide On Inflammatory Lipids In Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease At The Liver Meeting 2024
ALTHC Wainwright & Co. Reiterates Buy on Altimmune, Maintains $12 Price Target
ALTDow, S&P 500 Turn Lower; Altimmune Shares Slide
ALTU.S. stocks pared gains toward the end of trading, with the Dow Jones dropping around 80 points on Wednesday.
12 Health Care Stocks Moving In Wednesday's Intraday Session
ALTNasdaq Surges 100 Points; Crude Oil Rises 2%
ALTU.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Wednesday.
US Stocks Open Higher, Producer Prices Decline for 2nd Month
ALTU.S. stocks traded higher this morning, following the release of PPI data for August.
Altimmune Shares Fall Despite Fatty Liver Disease Study Meets Primary Goal
ALTAltimmune Stock Is Tanking: What's Going On?
ALTAltimmune Inc (NASDAQ: ALT) shares are falling Wednesday morning. The company announced topline results from its 12-week Phase 1b study of pemvidutide in subjects with non-alcoholic fatty liver disease.
Altimmune Announces 2-Week Phase 1b Clinical Trial Of Pemvidutide In Subjects With NAFLD Achieved Primary Endpoint
ALT10 Health Care Stocks Whale Activity In Today's Session
ALTThis whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Altimmune Option Alert: Oct 21 $21 Calls Sweep (32) near the Ask: 372 @ $3.901 vs 1012 OI; Earnings 11/8 After Close [est] Ref=$19.8901
ALT